The Tech Blog Writer Podcast - Inspired Tech Startup Stories & Interviews With Tech Leaders, Entrepreneurs And Innovators

Belfast-based Peter Keeling, CEO, and Founder of Diaceutics – the originator of the world's first diagnostic network for precision medicine. Having floated on the AIM market of the London Stock Exchange last year, Diaceutics is firmly committed to addressing the most pronounced issues hindering the traditional cancer testing landscape. Peter has driven Diaceutics to become a leader in innovative solutions that enable Pharma to leverage diagnostic testing globally. With over 30 years in international healthcare, Peter is a thought leader in precision medicine commercialization, a respected speaker at industry events and has published widely. Peter has also spent two extended periods in applied industrial research, including a year at MITís Pharmaceutical Program. The problem is a lack of collaboration between precision medicine stakeholders. It led to a broken testing ecosystem where only 50% of eligible patients in oncology getting access to the right treatment. The Diaceutics' Network solution has been purpo